Vir Biotechnology Inc (VIR)
9.72
-0.21
(-2.11%)
USD |
NASDAQ |
May 17, 16:00
9.72
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Free Cash Flow: -800.36M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -800.36M |
| September 30, 2023 | -668.34M |
| June 30, 2023 | -409.89M |
| March 31, 2023 | 928.35M |
| December 31, 2022 | 1.595B |
| September 30, 2022 | 1.567B |
| June 30, 2022 | 1.357B |
| March 31, 2022 | 555.04M |
| December 31, 2021 | -69.41M |
| Date | Value |
|---|---|
| September 30, 2021 | -148.52M |
| June 30, 2021 | -88.01M |
| March 31, 2021 | -237.98M |
| December 31, 2020 | -197.49M |
| September 30, 2020 | -153.44M |
| June 30, 2020 | -140.34M |
| March 31, 2020 | -155.32M |
| December 31, 2019 | -138.57M |
Free Cash Flow Range, Past 5 Years
-800.36M
Minimum
Dec 2023
1.595B
Maximum
Dec 2022
164.40M
Average
-140.34M
Median
Jun 2020
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals Inc | 3.479B |
| SeaStar Medical Holding Corp | -10.28M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.89M |
Free Cash Flow Related Metrics
| Free Cash Flow Per Share (Quarterly) | -0.8132 |
| Free Cash Flow to Equity (Quarterly) | -109.46M |
| Free Cash Flow to Firm (Quarterly) | -109.46M |
| Free Cash Flow Yield | -61.13% |